{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:00:29Z","timestamp":1793653229916,"version":"4.5.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Ovulation induction (OI) in patients with polycystic ovary syndrome (PCOS) remains challenging, and several biomarkers have been evaluated for their ability to predict ovulation. The predictive ability of candidate biomarkers, particularly with letrozole-based therapy in infertile PCOS women, remains inconclusive as it is yet to be evaluated in a prospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To assess the role of anti-M\u00fcllerian hormone (AMH), follicle-stimulating hormone (FSH), luteinising hormone (LH)\/FSH ratio, testosterone and free androgen index (FAI) as predictors of ovarian response to letrozole-based OI therapy during OI cycles in infertile women with PCOS from North India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>A prospective cohort study was conducted in a tertiary care hospital in north India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study enrolled 80 infertile women with PCOS, diagnosed according to the Rotterdam criteria. OI was conducted using letrozole with or without human menopausal gonadotropin. Baseline endocrine and metabolic parameters, including serum AMH, FSH, LH, testosterone and FAI levels, were measured using ELISA or chemiluminescence methods on day 2 of the menstrual cycle. Follicular response to OI was monitored by transvaginal ultrasonography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      Descriptive and inferential statistical analyses were conducted, including Mann\u2013Whitney, Kruskal\u2013Wallis, Independent\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test, analysis of variance, Fisher\u2019s exact test and receiver operating characteristic curve analysis. Data were processed using Microsoft Excel and analysed with SPSS software, version 25.0.\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 80 women enrolled, 74 responded to letrozole-based OI, while six were non-responders. Body mass index (BMI), serum testosterone and pre-treatment AMH levels significantly correlated with follicular response, with higher values linked to reduced responsiveness. The likelihood ratio+ (95% confidence interval) was 3.32 (2.45\u20135.06) for AMH, 1.97 (1.03\u20133.78) for BMI and 1.93 (1.22\u20133.08) for testosterone. The odds ratio for AMH was 2.88 (1.01\u20138.21) and 1.25 (1.02\u20131.53) for BMI. An AMH cut-off of \u226416.43 ng\/mL predicted ovarian response with an AUC of 0.88.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Pre-treatment AMH levels, along with BMI and serum testosterone, are significant predictors of ovarian response to letrozole-based OI in infertile women with PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_133_24","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T05:01:22Z","timestamp":1735016482000},"page":"240-245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Predictors of Response to Ovulation Induction Using Letrozole in Women with Polycystic Ovary Syndrome: A Prospective Cohort Study"],"prefix":"10.4103","volume":"17","author":[{"given":"Shanti","family":"Tholiya","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeta","family":"Mahey","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Kalaivani","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hem Chandra","family":"Sati","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Reproductive Biology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarthi K.","family":"Jayraj","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"R1-20241224","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/ncpendmet0510","article-title":"Ovulation induction in women with polycystic ovary syndrome","volume":"3","author":"Nader","year":"2007","journal-title":"Nat Rev Endocrinol"},{"key":"R2-20241224","first-page":"46","article-title":"The influence of AMH on IVF outcomes: A systematic review and meta-analysis","volume":"17","author":"Sunkara","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R3-20241224","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1472-6483(10)60379-3","article-title":"Clinical significance of serum concentration of anti-M\u00fcllerian hormone in obese women with polycystic ovary syndrome","volume":"15","author":"El-Halawaty","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"R4-20241224","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12905-022-01782-2","article-title":"Serum anti-M\u00fcllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age","volume":"22","author":"Butt","year":"2022","journal-title":"BMC Womens Health"},{"key":"R5-20241224","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"R6-20241224","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/1735-1995.193172","article-title":"Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone","volume":"21","author":"Jamil","year":"2016","journal-title":"J Res Med Sci"},{"key":"R7-20241224","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12902-023-01336-z","article-title":"Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"R8-20241224","doi-asserted-by":"crossref","first-page":"217","DOI":"10.29271\/jcpsp.2023.02.217","article-title":"Ovarian response can be predicted in women with PCOS who have ovulation induction with letrozole","volume":"33","author":"Akgul","year":"2023","journal-title":"J Coll Physicians Surg Pak"},{"key":"R9-20241224","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"R11-20241224","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1477-7827-11-115","article-title":"The influence of circulating anti-M\u00fcllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: A pilot study","volume":"11","author":"Amer","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"R12-20241224","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3889\/oamjms.2022.8691","article-title":"Anti-Mullerian hormone serum level as a predictor of responsiveness to clomiphene citrate therapy in Iraqi women with PCOS","volume":"10","author":"Rashid","year":"2022","journal-title":"Open Access Maced J Med Sci"},{"key":"R13-20241224","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s43032-023-01195-y","article-title":"Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS","volume":"30","author":"Malhotra","year":"2023","journal-title":"Reprod Sci"},{"key":"R14-20241224","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.fertnstert.2021.05.094","article-title":"Antim\u00fcllerian hormone to determine polycystic ovarian morphology","volume":"116","author":"Dietz de Loos","year":"2021","journal-title":"Fertil Steril"},{"key":"R15-20241224","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS):Revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"R16-20241224","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20241224","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","article-title":"The pregnancy in polycystic ovary syndrome II study: Baseline characteristics and effects of obesity from a multicenter randomized clinical trial","volume":"101","author":"Legro","year":"2014","journal-title":"Fertil Steril"},{"key":"R18-20241224","first-page":"2361","article-title":"Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility","volume":"83","author":"Imani","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R19-20241224","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10815-023-02749-4","article-title":"Effect of basal serum testosterone level on the ovarian response and the cumulative live birth rate in infertile women undergoing in vitro fertilization","volume":"40","author":"Wan","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"R20-20241224","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/09513590.2015.1076784","article-title":"Basal serum testosterone levels correlate with ovarian reserve and ovarian response in cycling women undergoing in vitro fertilization","volume":"32","author":"Xiao","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"R21-20241224","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1093\/oxfordjournals.humrep.a135742","article-title":"The prognostic value of basal luteinizing hormone:Follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques","volume":"10","author":"Tarlatzis","year":"1995","journal-title":"Hum Reprod"},{"key":"R22-20241224","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5114\/aoms.2019.82672","article-title":"How much insulin resistance in polycystic ovary syndrome? Comparison of HOMA-IR and insulin resistance (Belfiore) index models","volume":"15","author":"Lewandowski","year":"2019","journal-title":"Arch Med Sci"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_133_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:59Z","timestamp":1786647299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_133_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_133_24","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}